Healthcare companies sitting on piles of cash may start doing more deals next year as they seek products that can bolster sales. Pharmaceutical companies in particular, which have led the industry in deals over the last 12 months, are ready to divert their focus from cutting costs to making agreements that can help build product lines.
Trending:
Health companies sitting on cash may mean bigger deals